The machinery of macroautophagy Eaten alive: a history of macroautophagy The Atg8 and Atg12 ubiquitin‐like conjugation systems in macroautophagy Huntington’s disease pathogenesis is modified in vivo by Alfy/Wdfy3 and selective macroautophagy Discovery of Atg5/Atg7-independent alternative macroautophagy Beclin 1-mediated macroautophagy involves regulation of caspase-9 expression in cervical cancer HeLa cells BACE 2 degradation mediated by the […]
Genomic instability and cancer Genomic instability and colon cancer Apoptosis and genomic instability Genomic instability induced by ionizing radiation The connection between transcription and genomic instability The role of nuclear architecture in genomic instability and ageing Radiation-induced genomic instability Genomic instability—the engine of tumorigenesis? Genomic instability in laminopathy-based premature aging Chromosomal biomarkers of genomic instability
GENOMIC INSTABILITY Read More »
Aging, inflammation and the environment Molecular mechanisms of aging-associated inflammation Oxidative stress and vascular inflammation in aging Source of chronic inflammation in aging Exercise, inflammation and aging Para-inflammation in the aging retina Aging and inflammation in two epidemiological worlds Stress, inflammation, and aging Inflammation and the degenerative diseases of aging Inflammation in aging: cause, effect,
INFLAMMATION AGING Read More »
Biguanide-associated lactic acidosis: case report and review of the literature Lactic acidosis in biguanide-treated diabetics: a review of 330 cases Biguanides and NIDDM Pharmacophoric features of biguanide derivatives: an electronic and structural analysis Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide Outcome of Acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine Re-evaluation of a biguanide, metformin:
BIGUANIDE | BIGUANIDES Read More »
Sulfonylureas Sulfonylureas in NIDDM Sulfonylureas. Sulfonylureas Sulfonylureas Why, Which, and How? Sulfonylureas and Sulfonylthioureas. Effects on lipid profile of dipeptidyl peptidase 4 inhibitors, pioglitazone, acarbose, and sulfonylureas: meta-analysis of placebo-controlled trials Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6. 2 mutations State of the art paper Sulfonylureas and their use
Thiazolidinediones Nonhypoglycemic effects of thiazolidinediones Thiazolidinediones Thiazolidinediones: an update The mode of action of thiazolidinediones Metabolic and additional vascular effects of thiazolidinediones Thiazolidinediones in the treatment of insulin resistance and type II diabetes How safe is the use of thiazolidinediones in clinical practice? Unraveling the mechanism of action of thiazolidinediones Insulin resistance and its treatment
THIAZOLIDINEDIONES Read More »
Recent developments in synthetic α-glucosidase inhibitors: A comprehensive review with structural and molecular insight Synthesis of novel indenoquinoxaline derivatives as potent α-glucosidase inhibitors Studies on α-glucosidase inhibitors development: magic molecules for the treatment of carbohydrate mediated diseases Newer insights into the drug delivery approaches of α-glucosidase inhibitors Novel inhibitors with sulfamethazine backbone: synthesis and biological
Α-GLUCOSIDASE INHIBITORS Read More »
Comparative review of dipeptidyl peptidase‐4 inhibitors and sulphonylureas Pharmacology of dipeptidyl peptidase-4 inhibitors: similarities and differences Dipeptidyl peptidase‐4 (DPP‐4) inhibitors for type 2 diabetes mellitus Safety of dipeptidyl peptidase 4 inhibitors: a perspective review Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors Dipeptidyl peptidase‐4 inhibitors in the treatment of type 2 diabetes: a
DIPEPTIDYL PEPTIDASE 4 INHIBITORS Read More »
Molecular physiology of amylin The role of amylin in the control of energy homeostasis Amylin: history and overview Dose-response for glucagonostatic effect of amylin in rats Polymorphic fibrillar assembly of human amylin Amylin: a novel action in the brain to reduce body weight Analysis of amylin cleavage products provides new insights into the amyloidogenic region
Adapting proteostasis for disease intervention Biological and chemical approaches to diseases of proteostasis deficiency Proteostasis and aging The proteostasis network and its decline in ageing The biology of proteostasis in aging and disease Pathways of cellular proteostasis in aging and disease Aging as an event of proteostasis collapse Proteostasis impairment in protein-misfolding and-aggregation diseases Quality
